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ABSTRACT 
The health of an individual depends on his diet and lifestyle. The rapid 
modernization, fast food culture, stressful and speedy life leads too many 
serious health issues. Among such health issues Vatarakta is one. A 
chronic disease or illness is defined as a condition which develops 
gradually through years because of frequent and continuous exposure to 
abnormal dietary, lifestyle or environmental factors. In Vatarakta these 
lifestyle changes causing inflammatory changes to joint leading to pain 
and swelling. Vatarakta in Ayurveda is considered as one of chronic 
illness which is commonly seen affecting nearly 14-17% of population 
every year. Vatarakta is more distressing and common metabolic 
disorder prevalent in present era. Vatarakta is correlated with gout in 
modern science. Gout is an abnormality of purine metabolism causes 
hyperuricemia and deposition of monosodium urate crystals in 
joints. Pain is predominant symptom of gout; it disturbs day-to-day life of 
the patient. Shodhana Chikitsa is considered as the best line of treatment. 
Treatment aims to eliminate the Sanchita mala (Serum uric Acid) and to 
bring back Vata and Raktha to its normalcy. Among the Shodhana 
procedures Vasti and Virechana are considered as the main line of 
treatment for Vatarakta. Here in this study 100 subjects are randomly 
selected and grouped in 2 groups A and B, in Group A Ardhamatrika 
Niruha basti and in Group B Nimbamruthadi eranda Virechana is done. 
Both the therapy shows significant results in patients of Vatarakta. But 
after statistical test and percentage wise results Basti group shows more 
improvement in uric acid levels and other symptoms.  
 
INTRODUCTION 
The health of an individual depends solely 
on his/her diet and lifestyle. The rapid 
modernization in India, fast food culture, stressful 
and speedy life, prevalent in urban areas is 
spreading its wings in remote villages too. 
Nowadays human beings are vulnerable to many 
disorders due to their altered life style and food 
habits. The resultant diseases may manifest itself in 
a gradual way. In the initial phase there may be 
absence of the symptoms. At later stage there may 
be complex manifestations involving more than one 
joint. The illness may become chronic or of a long 
standing nature. One such affliction is Vatarakta 
(Gouty Arthritis).  
Vatarakta is caused by vitiation of Vata and 
Rakta.[1] Aggravated Vata blocked by vitiated Rakta, 
in turn leading to further aggravation of Vata. Thus 
aggravated Vata vitiates the Rakta leading to 
condition Vatarakta.[2] Vatarakta is a Roga related 
with KhaVaigunya of Raktavaha Srotas the vitiated 
Rakta gravitates and accumulates in the feet. In the 
initial stage, the hands and foot are affected. The 
illness then spreads all over the body like rat 
poison.[3,4] Due to the fluidity, mobility and subtle 
nature of Vata and Rakta it moves all over the body, 
while they move through blood vessels, they get 
obstructed in the joints which further aggravates 
them and the morbid matter get lodged there. Both 
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the Viruddha Aahara and Vihara will lead to this 
condition. [5-7] 
  It has two stages i.e., Uthana and Gambhira. 
Gambhira Vatarakta mainly affects Asthidhatu and 
causes Ruja which spreads as Aakhorvisha (rat 
poison).[8,9] Intense painful condition, initial site of 
manifestation i.e. involvement of hands and feet, 
and other clinical features can be compared with 
gout described in modern medicine. The gout is also 
known as “disease of kings” and also “king of 
diseases” in modern medicine. Gout is a metabolic 
disorder and inflammatory response to 
monosodium urate crystals formed secondary to 
hyperuricemia. In 21st century, gout remains the 
most common inflammatory arthritis in men over 
40 years old and in post–menopausal women, 
although more common in men (10:1). The number 
of cases rise with age, from 2/1000 in males aged 
18 - 44 and 34/1000 in males of age 45-65 years. 
Clinical varieties of Vatarakta are also 
elaborated according to the association of vitiated 
Dosha in the primary pathology of Vata and Rakta 
and are named as Vatadhika Vatarakta, Pittadhika 
Vatarakta, Kaphadhika Vatarakta and Raktadhika 
Vatarakta. All these symptoms of Vatarakta are 
much similar to that of gouty arthritis like swelling 
and pain which starts primarily on the big toe 
which spreads to other major and minor joints as 
like Akhuvisha /rat poison causing excessive pain, 
swelling, redness, deformity and finally affecting the 
mobility of an individual with the main underlying 
cause of increased Serum Uric Acid . 
The treatment of Vatarakta - Gouty Arthritis 
with increased serum uric acid levels is well 
explained in Ayurveda including Shodhana Chikitsa, 
Shamana Chikitsa and Rasayana Prayoga. Shodhana 
Chikitsa is considered as the best line of treatment 
for as the main line of approach is to eliminate the 
Sanchita mala (Serum uric Acid) and to bring back 
Vata and Rakta to its normalcy. Among the 
Shodhana procedures Vasti and Virechana are is 
considered as the main line of treatment for 
Vatarakta.[10] 
Hence for the present study it is planned to 
evaluate the efficacy of Vasti and Virechana in the 
management of Gouty Artritis/ Vatarakta. 
  
AIMS AND OBJECTIVES 
1. To study Vatarakta and Gouty Arthritis in detail.  
2. To evaluate and compare the efficacy of 
Ardhamatrika Vasti and Virechana in Vatarakta. 
3. To assess the effect of Vasti and Virechana on 
raised uric acid level in gouty arthritis. 
4. To assess the effect of Kokilaksha Kashaya on 
raised uric acid level. 
MATERIALS AND METHODS 
In this study, Hareetakyadi Churna was 
selected for Ama Pachana in both the groups. 
Madhu, Saindhava Lavana, Balaguduchyadi taila, 
Sathahwa Kalka and Dasamula Kashaya were used 
for Ardhamatrika Nirooha Vasti in Kala Vasti 
schedule in Group A, and Panchatikta ghrita 
guggulu snehapana followed by Nimbamrithadi 
Eranda Thaila virechana in Group B. 
Inclusion criteria 
• Subjects presenting with clinical features of 
Vatarakta/ Gouty Arthritis. 
• Subjects with chronicity of disease more than 6 
months and less than 5 yrs. 
• Subjects of either sex between age group of 20-
70 yrs. 
• Subjects fit for Basti Karma and Virechana 
karma. 
• Subject showing the uric acid level above 6mg/dl 
(Above Biological Range). 
Exclusion Criteria  
• Subjects with uncontrolled diabetes, systemic 
disorders and endocrine disorders. 
• Subjects with autoimmune disease of joints. 
• Subjects with infection and communicable 
diseases. 
• Subjects not fit for Basti Karma and Virechana 
karma. 
Parameters of the study  
Subjective parameters 
• Sandhi Graha (Stiffness of Joint) 
• Sandhi Shoola (Joint Pain) 
• Shotha (Inflammation) 
Objective Parameters 
• Serum Uric acid before and after treatment. 
• Vaivarnya (Colour of affected joint). 
• Sparsha Asahatva (Tenderness). 
• McGill pain scale for pain assessment 
Showing Grading of Parameters: Subjective Parameters 
Parameter Finding Points 
Sandhi Shula (pain) None 0 
 Mild 1 
 Moderate 2 
 Severe 3 
 Extreme 4 
Sandhi Graha (Stiffness) No stiffness 0 
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 Stiffness occasional, relieved by its own 1 
 Stiffness relieved by movements 2 
 Stiffness relieved by medication 3 
Shotha (swelling) None 0 
 Slight 1 
 Moderate 2 
 bulging beyond joint margins 3 
Objective Parameters 
Vaivarnya (Discolouration) No discolouration 0 
 Occasional, relieved by its own. 1 
 Present, but relieved by relief in swelling 2 
 Persistent, not relieved by medication 3 
Sparsha asahatva (tenderness) No tenderness 0 
 patient complains of pain 1 
 patient complains of pain and winces 2 
 patient complains of pain, winces and 
withdrew joint 
3 
Serum Uric acid before and after treatment 
 
Amapachana 
This is the first and foremost treatment 
before conducting any Shodhana Karma, as under 
the presence of Ama, Shodhana will not be proper. 
In this study Hareetakyadi Churna was taken, as it 
acts as Deepana, Pachana and Vatanulomana. It 
plays an important role in preparing the body for 
Pradhana Karma.  
Abhyanga 
Acharya Charaka quotes the Sthana of Vayu 
is Sparshanedriya and Adhishtana of Sparshanedriya 
is Twacha. Massage acts on three systems namely 
blood vascular system, lymphatic system and 
nervous system. The lymphatic system and blood 
vascular system are supplementary to each other. 
The lymphatic system offers an alternative route for 
the return of tissue fluid to the blood stream. By 
application of Taila in Abhyanga generates heat and 
thus stimulates lymphatic flow. 
The Veerya of the drug used in Taila for 
Abhyanga enters skin under the influence of 
Bhrajakagni. This helps to penetrate into deeper 
Dhatu, and potency of the drugs enters into all 
Srotas and exhibits its action.  
The properties of Balaguduchyaditaila used for 
Abhyanga in Vatarakta 
It has the ability to reduce Vata thereby 
reducing Shula. Owing to its Gunas like 
Snigdhasookshma it penetrates deep there by 
reducing the Vatadivikaras, drugs like Guduchi will 
act as Vatarakta hara, drugs are having Tikta, 
Kashaya Rasa, so it is much beneficial in Vatarakta. 
 
Swedana 
 Swedana Karma is a procedure by which 
a person is made to perspire. Klinna Dosha through 
the Snehapana will be liquefied by the Swedana 
therapy. The Dravikarana of the Dosha present in 
Sukshma Srotas takes place by Swedana. Swedana 
increases Agni, creates Komalatha, Ruchi, clears 
Srotas, and diminishes Tandra. 
Swedana stimulates Bhrajaka Pitta and 
Vyana Vata. It also enhances circulation of blood, 
thus carries toxins lying in the tissues to excretory 
organ such as skin, bowel etc. Thus the toxins are 
driven out from the tissues and brought to the 
bowels naturally, from where they are subsequently 
evacuated by means of Shodhana Karma. 
Probable Mode of Action of Vasti Therapy Drugs 
a) Madhu (Honey) 
It is considered as the best among the 
vehicles, as it contains various substances in it, 
which denotes its drug (potency of the drug) 
carrying capacity. Owing to its Sukshma Guna it 
reaches up to the micro channels, in turn carry the 
drug (potency of the drug) at the molecular level 
through the micro channels. Further it is 
Tridoshahara. 
In case of Vatarakta there is inflammation of 
joint and this inflammation is due to deposition of 
uric acid crystals. So use of Madhu in Vasti may 
reduce this inflammation as well as due to its 
Lekhana property. Madhu has property to stimulate 
the healing process and tissue regeneration. 
 
Before treatment After treatment 
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b) Saindhava 
Lavana in general are having the properties 
like Vishyandi, Sukshma, Tikshna, Ushna and 
Vataghna and promotes the evacuation of Bladder 
and Rectum. 
 Owing to the Sukshma property it helps 
the drug (potency of the drug) to reach in the Micro 
Channels, Saindhava mixed with Madhu is capable 
of liquefying the viscid Kapha and breaking it into 
minute particles for their easy elimination. Similarly 
it may liquefy the morbid Dosha Sanghata and 
breaks it into smaller particles by virtue of its 
Ushna and Tikshna property respectively and thus 
helps their elimination.  
Because of Sukshma and Vishyandi 
properties it helps to pass the drug molecules in the 
systemic circulation through mucosa. It also helps 
in the elimination of Vasti due to its irritant 
property. 
c) Sneha 
Sneha gets mixed with Madhu and 
Saindhava and forms a uniform mixture. Sneha 
counterparts some of irritating properties of both 
Madhu and Saindhava. Ghrita Kalpanas exclusively 
intensifies Vatapittahara effect.  
In Balaguduchyaditaila, Bala having 
Vatahara property, Balya and Brumhana, Guduchi 
has Tiktha rasa and Ushnaveerya so it is Vata hara 
but does not provokes Pitta, it is Madhura vipaka so 
it is Vatahara, Balya, Brumhana and Rakta 
prasadhaka. 
 Being a Sneha it can penetrate into micro-
channels. Thus, Balaguduchyaditaila is acting at the 
level of Rakta, Asthi and Majja Dhatu. 
d) Kalka 
Kalka gives thickness to the Vasti Dravya. 
We can use the fresh drugs in the form of Kalka, 
which containing volatile properties. This is one of 
the ingredients mainly according to the disease. 
Shatpushapa 
Shatapushpa is common Kalkadravya in 
Asthapana Vasti drugs. Kalka helps to disintegrate 
the Malas by increasing the osmotic permeability of 
the solution. We can use the fresh drugs in the form 
of Kalka, those which we cannot use for the 
decoction. In this study Shatahva was used as Kalka 
dravya because of its Katu rasa, Ushna Veerya, and 
Vatakaphahara and Deepana properties. 
e) Kashaya 
 This is the main content of Vasti Dravya. The 
drugs, which are water soluble we can use by this 
way. The Kashaya gives essential quantity to the 
Vasti Dravya for administration during preparation 
it gets mixed with above mixture. 
Dasamoola Kashaya: This was used as the 
Kashayadravya as it is generally Vatahara, 
Sophahara, Balya. It will act as Vatakaphahara and 
Agnideepana. 
Probable Mode of Action of Vasti 
As the Vatarakta is the Madhyama 
rogamarga Vyadhi and for the Madhyama 
rogamargavyadhi Vasti is the one of the best 
treatment modality. As, it has been explained in the 
classics that Vasti is considered as Ardha Chikitsa, 
whereas some Acharyas, have considered it as 
complete Chikitsa.  
The Asthapana drugs selected by their 
virtue of their property act on the vitiated Dosha 
and Dooshya (Dosha: Vata, pradhana Tridosha, 
Dooshya: Rasa, Rakta, Mamsa, Meda, Asthi, Majja). 
Vasti can act as a purificative, curative and 
preventive measure. Vasti due to purification, 
eliminates the excess of deranged metabolic waste 
and it in turn clears the Avarana of Vata and 
normalize the functions of Vyana and Apana. Once 
the proper purification is done then the digestive 
power is going to become normal and the proper 
metabolism starts which in turns help to form the 
Samyak Dhatus. 
Virechana  
Nimbamritadi eranda thailam is one of the 
most effective Sneha virechineeya oushadhi for 
rheumatological disease. It is Vatanulomana, 
Srotovishodhana, Balakara, Adhobhaga doshahara, 
Deepana, Shothahara. It is best used as a Sneha 
virechaneeya oushadhi in Raktha/Pitta involved 
Vata vikaras like Vataraktha. Here the oil due to its 
Gunas like Teekshna, Sookshma, Sara, Kashaya rasa, 
Madhura vipakam etc., pacifies Vata and Raktha and 
its Virechaneeya effect result in the elimination of 
Sanchita mala, that is serum uric acid in gouty 
arthritis. 
Observations 
General description of the subjects studied in the 
present series was as follows: 
Age: Observations of this study were in accordance 
with the findings of Gouty Arthritis in middle age. 
Vatarakta is caused because of irregular and 
perverted dietetic habits influencing on Jataragni. 
The middle age is more prone for committing such 
habits which will vitiate Jataragni and produce 
related conditions. 
Ahara: Subjects in the present study were more 
prone to take Samishaahara (more prone to non 
vegetarian diet). Apathya Ahara Vihara plays an 
important role in the pathogenesis of disease. 
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Intake of incompatible diet and sedentary life style 
may play an important role in the pathogenesis of 
Vatarakta. Virudhahara has been included in the 
Nidanas of Vatarakta. 
Agni: Most of the subjects in this study were having 
Mandagni. Mandagni is the root cause of Ama 
formation and it is the Ama which is responsible for 
the manifestation of the disease Vatarakta. Next is 
Vishamagni which is due to vitiated Vayu that plays 
a vital role in the manifestation of Vatarakta. 
Koshta: In present study maximum subjects were 
had Krurakosta and it is because of the Vata. 
Krurakosta leads to Malabaddata and Vishamagni, 
and may be cause for production of Ama. So 
Krurakosta may be the cause of Vatarakta.  
OBSERVATION ON DISEASE 
Table 1: Symptoms (Lakshana) Wise Distribution of 100 Subjects of Vatarakta 
Cardinal Symptoms Group A Group B Total % 
Sandhishoola 50 50 100 100 
Sandhishotha 50 50 100 100 
Sandhigraha 40 46 86 86 
Sparshasahatva 45 48 93 93 
Vaivarnata 37 40 77 77 
Table 2: Showing Serum Uric Acid Level of 100 Subjects of Vatarakta 
S.Uric Acid Group A Group B Total % 
6.1 to 7 04 02 06 06 % 
7.1 to 8 17 16 33 33 % 
8.1 to 9 15 18 33 33 % 
9.1 to 10 12 08 20 20 % 
10.1 to 11 02 06 08 08 % 
Katu, Amla, Lavana causes Rakta Dusti and 
Vata Vikruti. Most of subjects were using excessive 
in the form fried items and pickles. In classics it is 
told that Vatarakta starts with Pada where as in 
gout also first it affect metatarsophalangeal joint of 
big toe. All the subjects (100%) presented with 
Sandhi Shoola, Sandhi Shotha, Sandhi Graha, 
Sparshaasahitwa and Vaivarnyatha. This shows that 
the disease has taken a gross appearance. Maximum 
number of subjects came with high uric acid levels 
7- 10mg/dl which shows the high levels of uric acid 
level in patients showing symptoms of Vatarakta. 
Results 
In this study the effect of treatment was 
assessed on the basis of changes observed after the 
treatment in subjective and objective parameters. 
The results are discussed parameter wise as here 
under. 
Table 3: Showing Effect of Therapy on Subjective Parameters in Group A 
Parameter 
No. Of 
Patients 
Mean Mean 
Diff 
% relief S.D. S.E. ‘t’ P Remarks 
BT AT 
Sandhi Graha 50 2.64 0.66 1.98 75% 0.616 0.087 22.73 <0.001 S 
Sandhi Shoola 50 2.22 0.32 1.9 99.85% 0.670 0.094 20.04 <0.001 S 
Sandhi shodha 50 0.6 0.16 0.44 73.33% 0.803 0.113 3.869 <0.001 S 
Table 4: Showing Effect of Therapy on Objective Parameters in Group A 
Parameter 
No. Of 
Patients 
Mean Mean 
Diff 
% 
relief 
S.D. S.E. ‘t’ P Remarks 
BT AT 
Serum Uric acid 50 8.516 4.854 3.662 43% 1.0351 0.146 25.01 <0.001 S 
Affected Joint Colour 50 1.18 0.16 1.02 86.44% 0.836 0.118 8.622 <0.001 S 
Sparsha Asahatva 
(Tenderness) 
50 1.82 0.18 1.64 90.10% 0.741 0.104 15.63 <0.001 S 
MC Gill Pain Scale 50 3.21 0.92 2.2 71.34% 0.721 0.101 21.58 <0.001 S 
Table 5: Showing Effect of Therapy on Subjective Parameters in Group B 
Parameter 
No. Of 
Patients 
Mean Mean 
Diff 
% 
relief 
S.D. S.E. ‘t’ P Remarks 
BT AT 
Sandhi Graha 50 2.16 0.98 1.18 54.62% 0.589 0.083 14.21 <0.001 S 
Sandhi Shoola 50 1.96 1 0.96 48.97% 0.527 0.074 12.86 <0.001 S 
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Sandhi Shotha 50 0.86 0.24 0.62 72.09% 0.718 0.101 6.12 <0.001 S 
Table 6: Showing Effect of Therapy on Objective Parameters in Group B 
Parameter 
No Of 
Patients 
Mean Mean% 
S.D. S.E. ‘t’ P Remarks 
BT AT Diff Relief 
Serum Uric acid 50 8.74 5.87 2.86 32.83% 1.017 0.143 19.87 <0.001 S 
Affected Joint Colour 50 1.28 0.42 0.86 67.18% 0.632 0.089 9.60 <0.001 S 
Sparsha Asahatva 
(Tenderness) 
50 1.58 0.44 1.14 72.15% 0.721 0.102 11.17 <0.001 S 
MC GILL PAIN SCALE 50 2.82 1.38 1.44 51.06% 0.875 0.123 11.63 <0.001 S 
Table 7: Comparative Efficacy of Therapies on Subjective Parameters in Group A and Group B Using 
Unpaired Student’s ‘T’ Test 
Assessment 
Parameters 
No. of 
Patients 
Group A Group B 
Unpaired t Test 
(Group A vs Group B) 
Remarks 
Mean 
S.D. S.E. 
Mean 
S.D. S.E. 
T P 
(+/-) (+/-) (+/-) (+/-) 
Sandhi Graha 50 1.18 0.58 0.08 1.98 0.61 0.08 6.57 <0.05 S 
Sandhi Shoola 50 0.96 0.52 0.07 1.9 0.67 0.09 7.71 <0.05 S 
Sandhi Shotha 50 0.62 0.71 0.10 0.44 0.80 0.11 1.17 >0.05 NS 
Table 8: Showing Comparative Efficacy of Therapies on Objective Parameters in Group A and Group 
B Using Unpaired Student’s ‘T’ Test 
Table 9: Showing Total Effect Of Therapy On Different Parameters In Group A & B (In %) 
Cardinal Features 
Group A 
% 
Group B 
% 
B.T. A.F. B.T. A.F. 
Sandhi Graha 2.64 0.66 75% 2.16 0.98 54.62% 
Sandhi Shoola 2.22 0.32 99.85% 1.96 1 48.97% 
Sandhi Shotha 0.6 0.16 73.33% 0.86 0.24 72.09% 
Serum Uric Acid 8.516 4.854 43% 8.74 5.87 32.83% 
Affected Joint Colour 1.18 0.16 86.44% 1.28 0.42 67.18% 
Sparsha Asahatva (Tenderness) 1.82 0.18 90.10% 1.58 0.44 72.15% 
Mc gill pain scale 3.21 0.92 71.34% 2.82 1.38 51.06% 
Effect of Therapies on Subjective Parameters 
Sandhigraha: Therapies in both the group 
provided statistically highly significant result, 
Group A showed better result in percentage of 
improvement in this parameter which suggest that 
Vasti is more effective in the management of 
stiffness than Virechana. Sandhigraha is mainly due 
to vitiated Vata Dosha in Vaarakta. As Vasti is main 
line of treatment of Vata and as it spreads all over 
the body, does the Vata Niyamana (controls and 
maintains). In Vasti all the drugs are Vata 
Anulomana drugs which help in pacifying the 
vitiated Vata and it will reduce the Sandhi Graha. 
Sandhishoola: Even though, therapies in both the 
group provided statistically highly significant result, 
Group A showed better result in percentage of 
improvement in this parameter which suggest that 
Vasti is more effective in the management of pain 
than Virechana. Sandhishula is mainly caused by 
Vata Dosha in Vatarakta. In Vasti all the drugs are 
Vata Anulomana drugs which help in pacifying the 
vitiated Vata. Both Dasamoolakwatha and 
Balaguduchyadi Taila with the combined effect of 
Vasti has caused reduction in pain. 
Sandhi Sotha: Even though, therapies in both the 
group provided statistically highly significant result, 
Group A showed better result in percentage of 
improvement in this parameter which suggest that 
Vasti is comparatively more effective in the 
Assessment 
Parameters 
No. Of 
Patients 
Group A Group B 
Unpaired t Test 
(Group A vs Group B) 
Remarks 
Mean 
S.D. S.E. 
Mean 
S.D. S.E. 
T P 
(+/-) (+/-) (+/-) (+/-) 
Serum Uric acid 50 3.66 1.03 0.14 2.86 1.01 0.14 3.85 <0.05 S 
Affected Joint Colour 50 0.86 0.63 0.08 1.02 0.83 0.11 1.07 >0.05 NS 
Sparsha Asahatva 
(Tenderness) 
50 1.14 0.72 0.10 1.64 0.74 0.10 3.38 <0.05 S 
Mc gill pain scale 50 2.2 0.72 0.10 1.44 0.87 0.12 4.69 <0.05 S 
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management of swelling than Virechana. The 
vitiated Vata Dosha and Rakta Dhatu are 
responsible for Sandhi Shotha in Vatarakta. In Vasti 
drugs like Dasamoola is Shothahara and are Vata 
Anulomana which pacifies the vitiated Vata. The 
administration of Vasti expels this vitiated Vata 
Dosha and so it is helpful in reducing Sandhi Shotha. 
Effect of Therapies on Objective Parameters 
Serum Uric Acid: The therapies in Group A and 
Group B provided 43% and 32.83% improvements 
respectively on this Serum Uric Acid level. Even 
though, therapies in both the group provided 
statistically highly significant result, Group A 
showed better result in percentage of improvement 
in this parameter which suggest that Vasti is more 
effective in the management of S.Uric Acid level 
than Virechana. 
Affected Joint Colour: The therapies in Group A 
and Group B provided 86.44% and 67.18% 
improvements respectively on this symptom and 
which were statistically significant (P<0.01) in both 
the groups. Even though, therapies in both the 
group provided statistically highly significant result, 
Group A showed better result in percentage of 
improvement in this parameter which suggest that 
Vasti is more effective in the management of Joint 
colour than Virechana. 
Sparsha Asahatwa: The therapies in Group A and 
Group B provided 90.10% and 72.15% 
improvements respectively on this symptom. Even 
though, therapies in both the group provided 
statistically highly significant result, Group A 
showed better result in percentage of improvement 
in this parameter which suggest that Vasti is more 
effective in the management of Sparshaasahatva 
than Virechana. Sparshaasahatva is mainly caused 
by Vata Dosha along with Rakta in Vatarakta. In 
Vasti all the drugs used are Vata Anulomana and 
raktasudhikara drugs which help in pacifying the 
vitiated Vata and Rakta. Vedanashamaka Dravyas 
and the reduction in pain can be attributed to this 
property. 
Table 10: Overall Effects of Study on Cardinal Symptoms in Both Groups 
Remarks Group A Group B Total Percentage 
Marked relief Above 75 % 3 0 3 03% 
Moderate relief 50-75% 43 15 58 58% 
Mild relief 25%-50% 4 34 38 38% 
No relief Below 25% 0 1 1 01% 
 
 
DISCUSSION
The main causative factors for Vatarakta are 
excessive use of alcohol, high purine diet, non-
vegetarian diet, acidic and astringent foodstuffs, 
person leading sedentary life, excessive anger and 
emotional distress. Both Vata and Rakta play a 
major role in the pathogenesis of Vatarakta. 
Vitiated Raktadhatu obstructs the path of 
Vridhhvayu, in which the Vayu has to flow. Vridhh 
and obstructed Vata inturn vitiates the whole Rakta 
and this Dosha-dushyasammurchhana in joints 
manifests as Vatarakta. Pathya and Apathya are 
very important factors in the management of gout 
like metabolic disorder. So along with medicine 
disease can be better controlled by avoiding all such 
precipitating factors.  
CONCLUSION   
The prevalence of life style disorders is 
rising rapidly. The best thing which can be done in 
current scenario is to prevent it rather than cure. 
Present day life style, dietary habits, social and 
environmental situations have given rise to the 
number of patients of Gouty Arthritis /Vataraktha 
in the society. Various Vata hara and Rakta 
Prasadaka remedies along with Shodhana 
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procedures is the main protocol of Chikitsa. 
Recurrence of Vatarakta is very common; so long 
term treatment is essential for cure of the disease. 
In present study as per the clinical data, Vasti and 
Virechana are definitely effective in the 
management of Vatarakta, but Vasti is more 
effective than Virechana. 
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